Seqirus first to reach large-scale manufacture of cell-based influenza vaccines

21st June 2017 Uncategorised 0

Seqirus said it has achieved an industry first by producing a cell-based influenza vaccine on a commercial scale using a virus that has been grown in cells versus the traditional method of using chicken eggs.

More: Seqirus first to reach large-scale manufacture of cell-based influenza vaccines
Source: fierce